<p>A: AUC of age associated with significant fibrosis in HBeAg-positive PNALT patients. B: AUC of age associated with significant fibrosis in HBeAg-negative PNALT patients.</p
Although alanine aminotransferase (ALT) levels reflect the degree of liver damage, not all patients ...
<p>(A) Serum Fuc-Hpt levels in each stage of liver fibrosis in NAFLD patients. (B) ROC curves for Fu...
<p>Data are presented as the median (25<sup>th</sup>-75<sup>th</sup> percentile) for continuous vari...
<p>(A) Necroinflammation grade in HBeAg-positive patients. Significant necroinflammation (≥A2) was fo...
<p>Comparison of Ishak fibrosis scores among HBeAg-positive patients with normal ALT (p = 0.024).</p
Comparison of AUC among MELD, HVPG, sNa and noninvasive fibrosis markers to predict survival at 3 mo...
<p>Significant levels of necroinflammation (≥ G2), fibrosis (≥ S2), and necroinflammation (≥ G2) and...
Bar indicates mean values and lines indicated 95% of confidence interval. (A) FIB-4 distribution by ...
<p>AUC of HVPG, histologic fibrosis stage, APRI, FIB-4 and NAFLD fibrosis score for prediction of cl...
Univariate analysis of the factors and liver fibrosis stages in the PNALT patients.</p
<p>Predictors for advanced fibrosis in participants with NAFLD in the U.S. National Health and Nutri...
<p>(A) AUC of γ-glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), aspartate aminotransf...
<p>(A) Significant necroinflammation (≥ G2) occurred in 3.1% of subgroups of patients ≤ 30 years, 40...
Comparisons of characteristics of fibrosis stages by FIB-4 or transient elastogrpahy.</p
<p>The AUC of serum OPN was compared with the AUCs of other serum markers.</p><p>F, fibrosis; PPV, p...
Although alanine aminotransferase (ALT) levels reflect the degree of liver damage, not all patients ...
<p>(A) Serum Fuc-Hpt levels in each stage of liver fibrosis in NAFLD patients. (B) ROC curves for Fu...
<p>Data are presented as the median (25<sup>th</sup>-75<sup>th</sup> percentile) for continuous vari...
<p>(A) Necroinflammation grade in HBeAg-positive patients. Significant necroinflammation (≥A2) was fo...
<p>Comparison of Ishak fibrosis scores among HBeAg-positive patients with normal ALT (p = 0.024).</p
Comparison of AUC among MELD, HVPG, sNa and noninvasive fibrosis markers to predict survival at 3 mo...
<p>Significant levels of necroinflammation (≥ G2), fibrosis (≥ S2), and necroinflammation (≥ G2) and...
Bar indicates mean values and lines indicated 95% of confidence interval. (A) FIB-4 distribution by ...
<p>AUC of HVPG, histologic fibrosis stage, APRI, FIB-4 and NAFLD fibrosis score for prediction of cl...
Univariate analysis of the factors and liver fibrosis stages in the PNALT patients.</p
<p>Predictors for advanced fibrosis in participants with NAFLD in the U.S. National Health and Nutri...
<p>(A) AUC of γ-glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), aspartate aminotransf...
<p>(A) Significant necroinflammation (≥ G2) occurred in 3.1% of subgroups of patients ≤ 30 years, 40...
Comparisons of characteristics of fibrosis stages by FIB-4 or transient elastogrpahy.</p
<p>The AUC of serum OPN was compared with the AUCs of other serum markers.</p><p>F, fibrosis; PPV, p...
Although alanine aminotransferase (ALT) levels reflect the degree of liver damage, not all patients ...
<p>(A) Serum Fuc-Hpt levels in each stage of liver fibrosis in NAFLD patients. (B) ROC curves for Fu...
<p>Data are presented as the median (25<sup>th</sup>-75<sup>th</sup> percentile) for continuous vari...